ArticleJAMA internal medicine2023
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings.
Alexander C Egilman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it